Fetal thyroid function: Diagnosis and management of fetal thyroid disorders

Clinical Obstetrics and Gynecology

Volumn 40, Issue 1, 1997, Pages 16-31

  Fisher, Delbert A ^a,b  

^a QUEST DIAGNOSTICS NICHOLS INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; IODIDE; IODIDE PEROXIDASE; LIOTHYRONINE; LITHIUM; PROPYLTHIOURACIL; THIAMAZOLE; THYROGLOBULIN; THYROTROPIN; THYROXINE;

AMNION FLUID; CLINICAL TRIAL; CONFERENCE PAPER; CONGENITAL HYPOTHYROIDISM; FETUS DEVELOPMENT; HUMAN; INHERITANCE; IODINE DEFICIENCY; PRENATAL DRUG EXPOSURE; THYROID FUNCTION TEST; THYROID HORMONE METABOLISM;

FEMALE; FETAL DISEASES; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; MATERNAL-FETAL EXCHANGE; PREGNANCY; THYROID DISEASES; THYROID GLAND; THYROID HORMONES;

EID: 0031000888     PISSN: 00099201     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003081-199703000-00005     Document Type: Conference Paper

References (48)

1. Fisher DA. Endocrinology of fetal development. In Wilson JD, Foster DW, eds. Textbook of Endocrinology. 8th ed. Philadelphia: WB Saunders, 1992:1049-1077.
2. Centempre B, Jauniaux E, Calvo R, et al. Detection of thyroid hormones in human embryonic cavities during the first trimester of pregnancy. J Clin Endocrinol Metab. 1993;77:1719-1722.
3. Burrow GN, Fisher DA, Larsen PR. Maternal and fetal thyroid function. N Engl J Med. 1994;331:1072-1078.
4. Thorpe-Beeston JG, Nicolaides KH, McGregor AM. Fetal thyroid function. Thyroid. 1992;2:207-217.
5. Vulsma T, Gons MH, deVijlder JJM. Maternal-fetal transfer of thyroxine in congenital hypothyroidism due to a total organification defect or thyroid agenesis. N Engl J Med. 1989;321:13-16.
6. Polk DH, Reviczky A, Lam RW, et al. Thyrotropin releasing hormone in the ovine fetus: ontogeny and effect of thyroid hormone. Am J Physiol. 1991;260:E53-E58.
7. Docian-Sobkowska J, Malendowicz LK, Wozniak W. Morpometric studies on the development of human thyroid gland in early life. Histol Histopath. 1992;7:415-420.
8. Etling N. Concentration of thyroglobulin, iodine content of thyroglobulin and of iodoaminoacids in human neonates thyroid glands. Acta Paediatr Scand. 1977;66:97-102.
9. Klein AH, Fisher DA. Thyrotropin-releasing hormone-stimulated pituitary and thyroid gland responsneness and 3.5,3′ triio dothyronine suppression in fetal and neonatal lambs. Endocrinology. 1980;106:697-701.
10. Ares S, Pastor I, Quero J, et al. Thyroid gland volume as measured by ultrasonography in preterm infants. Acta Paediatr. 1995;84:58-62.
11. Fisher DA. Thyroid physiology in the perinatal period and during childhood. In Braverman LE, Utiger RD, eds. The Thyroid. 7th ed., Philadelphia: Lippincott-Raven, 1996:974-983.
12. Polk DH, Reviczky A, Wu SY, et al. Metabolism of sulfoconjugated thyroid hormone derivatives in developing sheep. Am J Physiol. 1994;266:E892-E896.
13. Calvo R, Obregon MJ, Ruiz de Ona C, et al. Congenital hypothyroidism as studied in rats: crucial role of maternal thyroxine but not of 3,5,3′ triiodothyronine in the protection of the fetal brain. J Clin Invest. 1990;86:889-899.
14. Fisher DA, Polk DH, Wu SY. Fetal thyroid metabolism: a pluralistic system. Thyroid. 1994;4:367-371.
15. Fisher DA. Screening for congenital hypothyroidism. Trends Endocrinol Metab. 1991;2:129-133.
16. La Franchi SH, Harma CE, Krainz PL, et al. Screening for congenital hypothyroidism with specimen collection at two time periods: results of the Northwest regional screening program. Pediatrics. 1985;76:734-740.
17. Glorieux J, Desjardens M, Letarte M, et al. Useful parameters to predict the eventual mental outcome of hypothyroid children. Pediatr Res. 1988;24:6-8.
18. Dubuis JM, Glorieux J, Richer F, et al. Outcome of severe congenital hypothyroidism: closing the developmental gap with early high dose levothyroxine treatment. J Clin Endocrinol Metab. 1996;81:222-227.
19. Klein AH, Meltzer S, Kenny FM. Improved prognosis in congenital hypothyroidism treated before age three months. J Pediatr. 1972;81:912-915.
20. Polk DH, Fisher DA. Fetal and neonatal thyroid physiology. In Polin RA, Fox WA, eds. Fetal and Neonatal Physiology. Philadelphia: WB Saunders, 1992:1842-1849.
21. Medeiros-Neto G, Stanbury JB. Inherited disorders of the thyroid system, Boca Raton: CRC Press, 1994:1-218.
22. Vassart G, Dumont JE, Refetoff S. Thyroid disorders. In Scriver CR, Beaudet AL, Sly WS, et al, eds. The Metabolic and Molecular Bases of Inherited Disease, New York: McGraw Hill, 1995;2883-2928.
23. Parks JS, Kinoshita E, Pfafle RW. Pit-1 and hypopituitarism, Trends Endocrinol Metab. 1993;4:81-85.
24. Medeiros Neto G, Herodotou DT, Rajan S, et al. A circulating, biologically inactive thyrotropin caused by a mutation in the beta subunit gene. J Clin Invest. 1996;97:1250-1256.
25. de Zegher F, Pernasetti F, Vanhole C, et al. A prenatal role of thyroid hormone evidenced by fetomaternal Pit-1 deficiency. J Clin Endocrinol Metab. 1995;80:3127-3130.
26. Sunthornthepvarakul T, Gottschalk ME, Hayashi Y, et al. Brief report: resistance to thyrotropin caused by mutations in the thyrotropin receptor gene. N Engl J Med. 1995;332:155-160.
27. Weinstein LS, Shenker A. G protein mutations in human disease. Clin Biochem. 1993;26:333-338.
28. VanSande J, Parma J, Tonaechera M, et al. Somatic and germline mutations of the TSH receptor gene in Thyroid disease. J Clin Endocrinol Metab. 1995;80:2577-2585.
29. Refetoff S, Weiss RE, Usala SJ. The syndrome of resistance to thyroid hormone. Endocrine Rev. 1993;14:348-399.
30. Sasaki S, Nakamura H, Tagami T, et al. Pituitary resistance to thyroid hormone associated with a base mutation in the hormone binding domain of the human 3,5,3′-triiodothyronine receptors-β. J Clin Endocrinol Metab. 1993;76:1254-1258.
31. Amino N, Tada H. Autoimmune thyroid disease/thyroiditis. In DeGroot LJ, Besser M, Burger HG, et al, eds. Endocrinology. 3rd ed. Philadelphia: WB Saunders, 1995:726-741.
32. Mitsuda N, Tamaki H, Amino N, et al. Risk factors for developmental disorders in infants born to women with Graves disease. Obstet Gynecol. 1992;80:359-364.
33. Matsuura N, Konishi J, Harada S, et al. The prediction of thyroid function in infants born to mothers with chronic thyroiditis. Endocrinol Japan. 1989;36:865-871.
34. Brown RS, Bellisario RL, Botero D, et al. Incidence of transient congenital hypothyroidism due to maternal thyrotropin-receptor blocking antibodies in over one million babies. J Clin Endocrinol Metab. 1996;81:1147-1151.
35. Surks MI, Sievert TR. Drugs and thyroid function. N Engl J Med. 1095;333:1688-1694.
36. Mehta PS, Mehta SJ, Vorherr H. Congenital iodide goitre and hypothyroidism: a review. Obstet Gynecol Surv. 1983;38:237-247.
37. Gardner DF, Cruikshank DF, Hays PM, et al. Pharmacology of propylthiouracil in pregnant hyperthyroid women: correlation of maternal propylthiouracil concentrations with cord serum thyroid function tests. J Clin Endocrinol Metab. 1986;62:217-223.
38. De Catte L, DeWolf D, Smitz J, et al. Fetal hyperthyroidism as a complication of amiodarone treatment for persistent fetal supra-ventricular tachycardia. Prenatal Diagn. 1994;14:762-765.
39. VanHerle AJ, Young RT, Fisher DA, et al. Intrauterine treatment of a hypothyroid fetus. J Clin Endocrinol Metab. 1975;40:474-477.
40. Man EB, Jones WS, Holden RH, et al. Thyroid function in human pregnancy, VIII. Retardation of progeny aged 7 years: relationships to maternal age and maternal thyroid function. Am J Obstet Gynecol. 1971;111:905-916.
41. Hadjzadeh M, Sinha AK, Pickard MR, et al. Effect of maternal hypothyroxinemia in the rat on brain biochemistry in adult progeny. J Endocrinol. 1990;124:387-396.
42. Wu SY, Chen WL, Fisher DA, et al. A 3,3′ diiodothyronine sulfate crossreactive compound in sera of pregnant women. J Clin Endocrinol Metab. 1994;78:1505-1509.
43. Wu SY, Polk DH, Fisher DA, et al. Identification of 3,3′ diiodothyronine sulfate (3,3′ T2S) as a fetal thyroid hormone derivative in maternal urine in sheep. Am J Physiol. 1995;268:E33-E39.
44. Abuhamad AZ, Fisher DA, Warsot SL, et al. Antenatal diagnosis and treatment of fetal goitrous hypothyroidism: case report and review of the literature. Ultrasound Obstet Gynecol. 1995;6:368-371.
45. Van Wassenaer AG, Kok JH, Ender TE, et al. Thyroxine administration to infants of less than 30 weeks gestational age does not increase plasma triiodothyronine concentrations. Acta Endocrinol (Copenh). 1993;129:139-146.
46. Perelman AH, Clemons RD. The fetus in maternal hyperthyroidism. Thyroid. 1992;2:225-228.
47. Druzin ML, Hutson JM, Edershiem TG. Re lationship of baseline fetal heart rate to gestational age and fetal sex. Am J Obstet Gynecol. 1986;154:1102-1103.
48. Momotani N, Ito K, Ohnishi H, et al. Deceptively high thyroid hormone levels in a neonate due to autoantibodies against thyroid hormones transferred from a mother with Graves disease. J Endocrinol Invest. 1992;15:201-204.